Figure 2: BCAS1 + cells in diffuse gliomas are morphologically different from BCAS1 + cells in healthy brain tissue. Oligodendrocyte precursor markers have become of great interest to identify new ...

Diffuse gliomas are malignant brain tumors and cannot be optimally examined by conventional imaging using MRI. Amino acid PET can better visualize the activity and spread of gliomas. An international ...

ARLINGTON, Va., June 26, 2025 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) focuses on the use of radiation therapy to treat adult patients with World Health ...

Genomic newborn screening for cancer risk: A retrospective cohort study. Cognitive outcomes following proton vs. photon radiotherapy for CNS non-germinomatous germ cell tumors: A Children’s Oncology ...

Newly updated guidelines from the American Society for Radiation Oncology (ASTRO) capture the World Health Organization (WHO)’s 2021 reclassification of glioblastoma as grade 4 adult-type diffuse ...

Primary Tumor Resection Before Systemic Therapy in Patients With Colon Cancer and Unresectable Metastases: Combined Results of the SYNCHRONOUS and CCRe-IV Trials Histone 3 (H3) K27M–mutant diffuse ...

“Receiving the Rare Pediatric Disease Designation for NEO100 is a crucial step forward in our mission to develop effective treatments for children facing diffuse high-grade gliomas,” said Dr. Thomas ...

Research team draws up criteria for PET-based examinations of malignant brain tumors. Diffuse gliomas are malignant brain tumors that cannot be optimally examined by means of conventional MRI imaging.

A new research paper titled "BCAS1 defines a heterogeneous cell population in diffuse gliomas" has been published in Oncotarget. Oligodendrocyte precursor markers have become of great interest to ...